The initial success of Viagra undeniably transformed the drug landscape, but betting in companies heavily reliant on generic versions presents a uncertain picture. Despite early returns were substantial, the expiration of patents and the appearance of less expensive alternatives have diminished market share. Thus, a thorough analysis of present fin